Skip to main content
Have a personal or library account? Click to login
Cancer incidence in HIV patients under HAART therapy in a HIV-1 F1 subtype endemic area Cover

Cancer incidence in HIV patients under HAART therapy in a HIV-1 F1 subtype endemic area

ARS Medica Tomitana
Volume 21 (2015): Issue 4 (November 2015)
By: ,   and    
Open Access
|Dec 2015
References

References

  1. 1. Centers for Disease, C. (1981). Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.(25), 305-308.
    Search in Google Scholar
  2. 2. Haverkos, H. W. & Curran, J. W. (1982). The current outbreak of Kaposi’s sarcoma and opportunistic infections.(6), 330-339.
    Open DOISearch in Google Scholar
  3. 3. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. (1987)., 1s-15s.
    Search in Google Scholar
  4. 4. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. (1992).(Rr-17), 1-19.
    Search in Google Scholar
  5. 5. Schneider, E., Whitmore, S., Glynn, K. M., Dominguez, K., Mitsch, A., & McKenna, M. T. (2008). Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.(Rr-10), 1-12.
    Search in Google Scholar
  6. 6. Marconi, V. C., Grandits, G. A., Weintrob, A. C., Chun, H., Landrum, M. L., Ganesan, A., . . . Infectious Disease Clinical Research Program, H. I. V. W. G. (2010). Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study., 14. doi: 10.1186/1742-6405-7-14
    Open DOISearch in Google Scholar
  7. 7. Miailhes, P., Trabaud, M. A., Pradat, P., Lebouche, B., Chevallier, M., Chevallier, P. & Trepo, C. (2007). Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.(5), 624-632. doi: 10.1086/520752
    Open DOISearch in Google Scholar
  8. 8. Lloyd-Smith, E., Brodkin, E., Wood, E., Kerr, T., Tyndall, M. W., Montaner, J. S., & Hogg, R. S. (2006). Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.(3), 445-450. doi: 10.1097/01.aids.0000206508.32030.92
    Open DOISearch in Google Scholar
  9. 9. Grover, S. A., Coupal, L., Gilmore, N., & Mukherjee, J. (2005). Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.(5), 586-591. doi: 10.1016/j.amjcard.2004.11.004
    Open DOISearch in Google Scholar
  10. 10. Madeddu, G., Fois, A. G., Calia, G. M., Babudieri, S., Soddu, V., Becciu, F. & Mura, M. S. (2013). Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?(2), 347-353. doi: 10.1007/s15010-012-0330-x
    Open DOISearch in Google Scholar
  11. 11. Menezes, A. M., Torelly, J., Jr., Real, L., Bay, M., Poeta, J., & Sprinz, E. (2011). Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil.(10), e26042. doi: 10.1371/journal.pone.0026042
    Open DOISearch in Google Scholar
  12. 12. Chen, C. H., Chung, C. Y., Wang, L. H., Lin, C., Lin, H. L., & Lin, H. C. (2015). Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention., 133. doi: 10.1186/s12885-015-1099-y
    Open DOISearch in Google Scholar
  13. 13. D’Souza, G., Wiley, D. J., Li, X., Chmiel, J. S., Margolick, J. B., Cranston, R. D., & Jacobson, L. P. (2008). Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.(4), 491-499. doi: 10.1097/QAI.0b013e31817aebfe
    Open DOISearch in Google Scholar
  14. 14. Hessol, N. A., Pipkin, S., Schwarcz, S., Cress, R. D., Bacchetti, P., & Scheer, S. (2007). The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.(10), 1143-1153. doi: 10.1093/aje/kwm017
    Open DOISearch in Google Scholar
  15. 15. Louie, J. K., Hsu, L. C., Osmond, D. H., Katz, M. H., & Schwarcz, S. K. (2002). Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.(7), 1023-1027. doi: 10.1086/343862
    Open DOISearch in Google Scholar
  16. 16. Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P. & Lundgren, J. D. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.(9939), 241-248. doi: 10.1016/s0140-6736(14)60604-8
    Open DOISearch in Google Scholar
  17. 17. Stanojevic, M., Alexiev, I., Beshkov, D., Gokengin, D., Mezei, M., Minarovits, J., . . . Paraskevis, D. (2012). HIV1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity.(1), 28-36.
    Search in Google Scholar
  18. 18. Paraschiv, S., Otelea, D., Dinu, M., Maxim, D., & Tinischi, M. (2007). Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains.(2), 123-128. doi: 10.1016/j.ijid.2005.11.006
    Open DOISearch in Google Scholar
  19. 19. Paraschiv, S., Foley, B., & Otelea, D. (2011). Diversity of HIV-1 subtype C strains isolated in Romania.(2), 270-275. doi: 10.1016/j.meegid.2010.07.002
    Open DOISearch in Google Scholar
  20. 20. Bandea, C. I., Ramos, A., Pieniazek, D., Pascu, R., Tanuri, A., Schochetman, G., & Rayfield, M. A. (1995). Epidemiologic and evolutionary relationships between Romanian and Brazilian HIV-subtype F strains.(3), 91-93. doi: 10.3201/eid0103.950305
    Open DOISearch in Google Scholar
  21. 21. Manolescu, L., Temereanca, A., Diaconu, C. C., & Ruta, S. (2011). Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patients.(4), 6439-6449.
    Search in Google Scholar
  22. 22. Guimaraes, M. L., Vicente, A. C., Otsuki, K., da Silva, R. F., Francisco, M., da Silva, F. G. & Bello, G. (2009). Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates., 39. doi: 10.1186/1742-4690-6-39
    Open DOISearch in Google Scholar
  23. 23. Lai, A., Ciccozzi, M., Franzetti, M., Simonetti, F. R., Bozzi, G., Binda, F., . . . Zehender, G. (2014). Local and global spatio-temporal dynamics of HIV-1 subtype F1.(2), 186-192. doi: 10.1002/jmv.23783
    Open DOISearch in Google Scholar
  24. 24. Breslow, N. E. (1987).(Vol. no. 82): International Agency for Research on Cancer.
    Search in Google Scholar
  25. 25. Jensen, O. M., Parkin, D. M., MacLennan, R., Muir, C. S., & Skeet, R. G. (1991).(Vol. No. 95): International Agency for Research on Cancer.
    Search in Google Scholar
  26. 26. VOLUMUL I: POPULAŢIA STABILĂ (REZIDENTĂ) – STRUCTURA DEMOGRAFICĂ. (2011). 2015, from
    Search in Google Scholar
DOI: https://doi.org/10.1515/arsm-2015-0049 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Journal RSS Feed
Language: English
Page range: 217 - 222
Published on: Dec 30, 2015
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
HIV-1 F1 variants,
cancer,
neoplasms incidence
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 S. Chirila, L.T. Hangan, S. Rugina, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 21 (2015): Issue 4 (November 2015)
Previous article
Next article